The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in Adults
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Respiratory viruses, such as those that cause colds and influenza, are very common in the general population. The average adult will experience between 2 and 4 viral respiratory illnesses each year. It is known that respiratory viruses can cause flare-ups of chronic lung diseases such as asthma and chronic obstructive pulmonary disease. In children with CF, respiratory viral infections have been identified in nearly half of all exacerbations and are associated with a decline in lung function and increased frequency of hospital admission and acquisition of new bacterial pathogens.
Currently, little is known about the impact of viral infections on the course of CF lung disease in adults and no large-scale prospective studies in this area have been performed to date. It is unknown how often respiratory viruses can be found in patients with CF when they are well and what consequences they have on the course of exacerbations of CF lung disease. This study will identify the frequency of common viral infections in adults with CF and determine the effects they have on lung function, the rate and diversity of bacterial infection and patients' treatment burden. The information gained from this study will lead to improved prevention and treatment of respiratory infections in CF.
| Condition |
|---|
|
Cystic Fibrosis |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in Adults. |
- Identification of respiratory viruses in sputum, nose- or throat-swabs [ Time Frame: 12 months ] [ Designated as safety issue: No ]A panel of 6 viruses will be tested for using polymerase chain reaction (PCR)technology: adenovirus, rhinovirus, metapneumovirus, parainfluenza virus 1-3, influenza A,B&C and respiratory syncytial virus
Biospecimen Retention: Samples Without DNA
Serum
| Enrollment: | 100 |
| Study Start Date: | December 2010 |
| Study Completion Date: | April 2012 |
| Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Adults with cystic fibrosis attending the Manchester Adult Cystic Fibrosis Centre, Manchester, UK
Inclusion Criteria:
- Patients with cystic fibrosis attending Manchester Adult CF Centre
- Age ≥18 years
- Capable of providing written informed consent
- Able and willing to provide required samples and meet visit schedule
Exclusion Criteria:
- Previous lung transplantation
Contacts and Locations| United Kingdom | |
| University Hospital of South Manchester NHS Foundation Trust | |
| Manchester, Lancashire, United Kingdom, M23 9LT | |
| Principal Investigator: | William G Flight, MBChB | University Hospital of South Manchester NHS FoundationTrust |
More Information
Additional Information:
No publications provided
| Responsible Party: | University Hospital of South Manchester NHS Foundation Trust |
| ClinicalTrials.gov Identifier: | NCT01238081 History of Changes |
| Other Study ID Numbers: | 2010CF004 |
| Study First Received: | November 9, 2010 |
| Last Updated: | May 31, 2012 |
| Health Authority: | United Kingdom: National Health Service |
Keywords provided by University Hospital of South Manchester NHS Foundation Trust:
|
Cystic fibrosis |
Additional relevant MeSH terms:
|
Cystic Fibrosis Fibrosis Pancreatic Diseases Digestive System Diseases Lung Diseases |
Respiratory Tract Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 23, 2013